Implementing a Case-management Intervention for Frequent Users of the Emergency Department in French-speaking Switzerland

NCT ID: NCT03641274

Last Updated: 2019-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-20

Study Completion Date

2020-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background. Emergency department (ED) overcrowding represents a significant public health problem in developed countries. Frequent users of the emergency departments (FUEDs; reporting 5 or more ED visits in the past year) are often affected by medical, psychological, social, and substance use problems and account for a disproportionately high number of ED visits. Past research indicates that the case management (CM) intervention is a promising way to reduce ED overcrowding and improve FUEDs' quality of life. There is, however, very limited knowledge about how to disseminate and implement this intervention on a large scale to diverse clinical settings, including community hospitals and non-academic centers. This research project aims to implement a CM intervention tailored to FUEDs in the public hospitals with ED in the French-speaking region of Switzerland and to evaluate both the implementation process and effectiveness of the CM intervention. Methods. This research project will examine both implementation and clinical outcomes. The implementation part of the study will describe quantitatively and qualitatively factors that influence the implementation process; the investigators will also examine implementation effectiveness (i.e., whether the implementation of the CM intervention in the ED was successful or not). The clinical part of the study will evaluate participants' trajectories on clinical variables (e.g., quality of life, ED use) after receiving the CM intervention. Discussion. This research project will contribute to implementation science by providing key insights into the processes for implementing CM into broader practice. This research project is also likely to have both clinical and public health implications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Frequent users of the emergency departments (FUEDs) and other health care services are of much interest to clinicians, administrators and researchers. Emergency department (ED) overuse is linked to ED overcrowding, which in turn has a negative impact on patients and health system outcomes. There are over 1.4 million annual ED visits in Switzerland, with 84% of EDs reporting overcrowding. FUEDs made up 4.4% of the patient population and made 12.1% of all visits at the Lausanne University Hospital ED. Driving this high use of health care services is the fact that FUEDs often suffer from chronic medical diseases, including heart disease, pulmonary disease and cancer, at high rates, in addition to mental illness and substance use disorders. CM has been shown to be a promising intervention to reduce ED overuse by frequent users in research settings; however, there is limited knowledge about how to disseminate and implement a CM intervention for FUEDs on a large scale to diverse clinical settings, including community hospitals and non-academic centers.

The research project has the following three specific aims:

1. Develop and disseminate a practical CM intervention for FUEDs to several hospitals in the French-speaking region of Switzerland.
2. Study the process of implementation of the intervention.
3. Study FUEDs' trajectories on health outcomes (e.g., ED use, health care reorientation and quality of life) after receiving the CM intervention.

This research project is an observational study with a hybrid study design, measuring both implementation variables and clinical outcomes relating to the dissemination and implementation of the CM intervention. The implementation part of the study uses a mixed methods design (i.e., using both qualitative and quantitative analyses) to describe both qualitatively and quantitatively factors that may influence implementation process. The clinical part of the study uses a within-subject (pre-post intervention) design to evaluate participants' trajectories after receiving the CM intervention.

The whole research project will take place over five phases.

Phases 1-2. Development and exploration Procedures. The I-CaM research team will develop the CM Toolkit, the implementation program, the team member selection-support materials and the informational announcement to be disseminated to hospitals in the French-speaking region of Switzerland. Specifically, the research team will develop and send by email a survey aiming to gauge interest and needs regarding the CM intervention to all eligible hospitals (to key staff, Chief of Emergency Department). The I-CaM research team will follow up with more information about the CM intervention and the study procedures. Then, interested parties will participate in a one-day workshop at Lausanne University Hospital, during which key staff will receive training on the CM intervention, on the implementation science and on the study procedures in general. Following the workshop, all sites agreeing to participate will a) be included in the study and b) complete a questionnaire and participate in a semi-structured interview (assessing implementation outcomes). Further, the same assessment will be conducted with hospitals not interested in participating in the study, in face-to-face or by phone and mail depending upon possibilities (i.e., disinterest analysis).

Phase 3. Preparation Procedures. Included sites will then prepare for implementation of the CM intervention; sites will first identify CM intervention team members, including strategical and operational champions and clinicians. Whereas the strategical champion (i.e., leader) will promote and hold the implementation project, the operational champion will support its implementation and application and supervise clinicians who will be in charge of the CM intervention administration. Next, available resources will be established at each source and data collection and storage systems will be finalized to gather data on health service and implementation outcomes by the research team. The I-CaM research team will also conduct trainings for the CM team to relevant local staff. Finally, at the end of the preparation phase, champions and clinicians involved in the project on-site will complete a questionnaire.

Phase 4. Operation The operation phase. The CM intervention will be implemented at all sites included in the study. At each site, patients fulfilling the inclusion criteria will be contacted by the case managers. The number of participants included will depend upon each site resources. If possible (depending upon resources on each site), eligible patients having been treated in the ED in the 10 days prior the recruitment window will be contacted by phone and proposed to come back to the ED to participate in the study. Remaining FUEDs (i.e., the FUEDs not invited to participate in the study) will receive usual care. When first meeting the participant, the case managers will present the study and examine the exclusion criterion. If the patient does not have any exclusion criteria and is interested in participating, the case managers will conduct the informed consent process. After providing written consent, participants will receive the CM intervention. After each inclusion on site, the case managers will up-date the I-CaM research team in charge of the clinical assessment (i.e., baseline and follow-up assessments of the clinical variables to describe participants' trajectories). The I-CaM research team will contact participants and conduct the baseline assessment within 10 days following the inclusion. Participants will then complete follow-up assessments at 3, 6 and 12 months post-baseline. Other clinical variables will be directly extracted from medical records on-site by the I-CaM research team. At the end of the operation phase, the research team will conduct semi-structured interviews with case managers and champions. Both champions and case managers will also complete a questionnaire.

Phase 5. Sustainability Procedures. Following the implementation of the CM intervention, the sites will continue the CM programs at their discretion. The I-CaM research team will monitor the activity at each site and will be available for as-needed support to all sites. Clinical outcomes (i.e., ED use, quality of life, etc.) will not be measured over this finale phase. At the end of the sustainability phase, the research team will conduct a semi -structured interview with clinicians and champions. Both champions and clinicians will also complete a survey.

* The development and exploration phases (no patient recruited) started in August 2017 and will end in September 2018.
* The preparation phase (no patient recruited) started in March 2018 and will end in December 2018.
* The operation phase (patients' recruitment start; assessment of health-related outcomes) will start in October 2018 and end in April 2019.
* The sustainability phase (patients receive the CM intervention but health-related outcomes are not assessed) will start in April 2019 and end in November 2020.

Data Analysis Plan Implementation measures analysis. Descriptive statistics will be used to describe participants' characteristics and to report implementation outcomes. The investigators will also test implementation measure changes over time. Given the expected small sample size regarding implementation outcomes, these analyses will be triangulated with qualitative data. Specifically, interview contents will be transcribed and explored to identify participants' recurring codes and categories; the investigators will use conventional content analysis (i.e., a systematic process of coding and classification) \[1\] using a qualitative software (i.e., Atlas.ti or NVivo) to examine qualitative data.

Clinical outcomes. Data will be screened for missing cases, outliers, and normality of distributions using descriptive statistics and plots. The investigators will take appropriate steps to deal with missing data. First, they will conduct analyses to detect missingness patterns and test whether they may be considered "ignorable."\[2\] If more than 5% of outcome data are missing,\[3\] the sample will be divided into 2 groups (i.e., missing, not missing), and fully observed variables to predict missingness on the affected outcome will be used. If fully observed variables are not significant predictors, missingness may be considered as "observed at random" and fulfilling some criteria for "missing completely at random" (MCAR) assumptions. In that case, the investigators will use multiple imputations procedures for measured outcomes and direct maximum likelihood estimation for structural models. If data missingness is non ignorable (MNAR), pattern-mixture models with multiple imputation to model the missingness mechanism will be used.

Main analyses will comprise multilevel models (i.e., MLM; mixed effects model) \[4\] utilizing appropriate distributions for the outcome variables (e.g., Poisson, negative binomial, normal). MLM examine the effect of time (after receiving the CM intervention) on clinical outcomes (e.g., quality of life, self-efficacy). MLM is appropriate to handle nonindependence data. Specifically, data will be clustered by participants (i.e., repeated measures) and by hospitals. MLM does not assume independence of observations. Dependence is modeled through random effects (representing different sources of variability in the data). The investigators will include sources of random variability at the group level accounting for between-group differences and another random effects for the individual accounting for within-person differences in the repeated measures. MLM will be adjusted for demographic variables (i.e., age and gender), health-care utilization (including ED use), at-risk behaviors (e.g., alcohol use disorders) and health status. Descriptive statistics will be conducted on SPSS and MLM on STATA. The significance level will be set at p = .05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frequent Users of Emergency Department (FUEDs)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Frequent users of emergency departement

FUEDs receiving the CM intervention in sites participating in the research project will be assessed over time on clinical variables (see inclusion and exclusion criteria)

Case-management intervention for frequent users of the emergency department

Intervention Type OTHER

The CM intervention to be implemented is an evidence-based practice. It consists of individualized services based on a detailed baseline evaluation using validated scales to identify all of the social and medical needs of each FUED. The CM team provides counseling and education on health care utilization, substance abuse and the social determinants of health directly to the FUEDs, using skills such as motivational interviewing and cross-cultural competences. Additionally, the CM team provides concrete services including, referral to psychiatric or substance abuse treatment, or medical services (such as a GP or medical specialist), on a case-by-case basis. Another key element of the CM intervention is to connect all health care or social service providers within the hospital or in the community, promoting continuity of care and improving the FUEDs' ability to navigate the complex health care system.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Case-management intervention for frequent users of the emergency department

The CM intervention to be implemented is an evidence-based practice. It consists of individualized services based on a detailed baseline evaluation using validated scales to identify all of the social and medical needs of each FUED. The CM team provides counseling and education on health care utilization, substance abuse and the social determinants of health directly to the FUEDs, using skills such as motivational interviewing and cross-cultural competences. Additionally, the CM team provides concrete services including, referral to psychiatric or substance abuse treatment, or medical services (such as a GP or medical specialist), on a case-by-case basis. Another key element of the CM intervention is to connect all health care or social service providers within the hospital or in the community, promoting continuity of care and improving the FUEDs' ability to navigate the complex health care system.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being a community or academic public hospital in French-speaking Switzerland
* Being interested in implementing the CM intervention


* Being ≥18 years
* Being able to communicate in a language that is spoken by the local team or a professional interpreter
* Reporting ≥5 visits in the ED in the past 12 months

Exclusion Criteria

Clinical part of the study:


* Presenting less than two vulnerability dimensions in addition to ED recurrent use \[17\]
* Being unable to provide informed consent
* Planning to stay in Switzerland less than 18 months
* Being not expected to survive at least 18 months
* Awaiting for incarceration or being currently incarcerated
* Having a family member already enrolled in the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lausanne Hospitals

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Patrick Bodenmann

Head of Vulnerable Populations Centre, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patrick Bodenmann, MD MSc

Role: PRINCIPAL_INVESTIGATOR

University of Lausanne Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital du Jura Bernois

Saint-Imier, Canton of Bern, Switzerland

Site Status RECRUITING

Hôpital du Jura

Delémont, Canton of Jura, Switzerland

Site Status RECRUITING

Hôpital Intercantonal de la Broye (HIB)

Payerne, Canton of Vaud, Switzerland

Site Status RECRUITING

Etablissements hospitaliers du Nord Vaudois (eHnv)

Yverdon-les-Bains, Canton of Vaud, Switzerland

Site Status RECRUITING

Hôpital du Valais

Sion, Valais, Switzerland

Site Status RECRUITING

Hôpital Fribourgeois

Fribourg, , Switzerland

Site Status RECRUITING

Hôpitaux Universitaires de Genève (HUG)

Geneva, , Switzerland

Site Status RECRUITING

Hôpitaux Neuchâtelois (HNE)

Neuchâtel, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Patrick Bodenmann, MD, MSc

Role: CONTACT

0041213144937

Veronique S Grazioli, PhD

Role: CONTACT

1141 21 314 23 72

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jacqueline Beutel

Role: primary

Dumeng Décosterd, Dr

Role: primary

Yvan Fournier, Dr

Role: primary

Julien Ombelli, Dr

Role: primary

Redouane Bouali, Dr

Role: primary

Vincent Ribordy, Dr

Role: primary

Juia Ambrosetti, Dr

Role: primary

Vincent Della Santa, Dr

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov;15(9):1277-88. doi: 10.1177/1049732305276687.

Reference Type BACKGROUND
PMID: 16204405 (View on PubMed)

2. Allison PD: Missing data. Thousand Oaks, CA: Sage; 2001.

Reference Type BACKGROUND

3. Tabachnick BG, Fidell LS: Using Multivariate Statistics. 5th edn. Boston: Allyn and Bacon; 2007.

Reference Type BACKGROUND

Kwok OM, Underhill AT, Berry JW, Luo W, Elliott TR, Yoon M. Analyzing Longitudinal Data with Multilevel Models: An Example with Individuals Living with Lower Extremity Intra-articular Fractures. Rehabil Psychol. 2008 Aug;53(3):370-386. doi: 10.1037/a0012765.

Reference Type BACKGROUND
PMID: 19649151 (View on PubMed)

5. Normalization Process Theory On-line Users' Manual, Toolkt and NoMad instrument [http://www.normalizationprocess.org]

Reference Type BACKGROUND

Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004 Mar;13(2):299-310. doi: 10.1023/B:QURE.0000018486.91360.00.

Reference Type BACKGROUND
PMID: 15085902 (View on PubMed)

Chamberlain P, Brown CH, Saldana L. Observational measure of implementation progress in community based settings: the Stages of Implementation Completion (SIC). Implement Sci. 2011 Oct 6;6:116. doi: 10.1186/1748-5908-6-116.

Reference Type BACKGROUND
PMID: 21974914 (View on PubMed)

Saldana L, Chamberlain P, Bradford WD, Campbell M, Landsverk J. The Cost of Implementing New Strategies (COINS): A Method for Mapping Implementation Resources Using the Stages of Implementation Completion. Child Youth Serv Rev. 2014 Apr 1;39:177-182. doi: 10.1016/j.childyouth.2013.10.006.

Reference Type BACKGROUND
PMID: 24729650 (View on PubMed)

Johnson MO, Rose CD, Dilworth SE, Neilands TB. Advances in the conceptualization and measurement of Health Care Empowerment: development and validation of the Health Care Empowerment inventory. PLoS One. 2012;7(9):e45692. doi: 10.1371/journal.pone.0045692. Epub 2012 Sep 19.

Reference Type BACKGROUND
PMID: 23029184 (View on PubMed)

10. French adaptation of the general self- efficacy scale - Auto-efficacité généralisée [http://userpage.fu-berlin.de/~health/french.htm]

Reference Type BACKGROUND

11. Consortium H-E: Comparative report of health literacy in eight EU member states. The European health literacy survey HLS-EU. 2012.

Reference Type BACKGROUND

Walton MA, Ngo QM, Chermack ST, Blow FC, Ehrlich PF, Bonar EE, Cunningham RM. Understanding Mechanisms of Change for Brief Alcohol Interventions Among Youth: Examination of Within-Session Interactions. J Stud Alcohol Drugs. 2017 Sep;78(5):725-734. doi: 10.15288/jsad.2017.78.725.

Reference Type BACKGROUND
PMID: 28930060 (View on PubMed)

Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.

Reference Type BACKGROUND
PMID: 28851459 (View on PubMed)

14. Moullin JC, Erhart MG, Torres EM, Aarons GA: 'Development and testing of a brief EBP implementation intentions scale using Rasch analysis. In Society for Implementation Research Collaboration (SIRC); Seattle, USA. 2017

Reference Type BACKGROUND

Jacobs SR, Weiner BJ, Bunger AC. Context matters: measuring implementation climate among individuals and groups. Implement Sci. 2014 Apr 17;9:46. doi: 10.1186/1748-5908-9-46.

Reference Type BACKGROUND
PMID: 24742308 (View on PubMed)

Shea CM, Jacobs SR, Esserman DA, Bruce K, Weiner BJ. Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci. 2014 Jan 10;9:7. doi: 10.1186/1748-5908-9-7.

Reference Type BACKGROUND
PMID: 24410955 (View on PubMed)

Bodenmann P, Baggio S, Iglesias K, Althaus F, Velonaki VS, Stucki S, Ansermet C, Paroz S, Trueb L, Hugli O, Griffin JL, Daeppen JB. Characterizing the vulnerability of frequent emergency department users by applying a conceptual framework: a controlled, cross-sectional study. Int J Equity Health. 2015 Dec 9;14:146. doi: 10.1186/s12939-015-0277-5.

Reference Type BACKGROUND
PMID: 26645272 (View on PubMed)

Bodenmann P, Velonaki VS, Griffin JL, Baggio S, Iglesias K, Moschetti K, Ruggeri O, Burnand B, Wasserfallen JB, Vu F, Schupbach J, Hugli O, Daeppen JB. Case Management may Reduce Emergency Department Frequent use in a Universal Health Coverage System: a Randomized Controlled Trial. J Gen Intern Med. 2017 May;32(5):508-515. doi: 10.1007/s11606-016-3789-9. Epub 2016 Jul 11.

Reference Type BACKGROUND
PMID: 27400922 (View on PubMed)

Bieler G, Paroz S, Faouzi M, Trueb L, Vaucher P, Althaus F, Daeppen JB, Bodenmann P. Social and medical vulnerability factors of emergency department frequent users in a universal health insurance system. Acad Emerg Med. 2012 Jan;19(1):63-8. doi: 10.1111/j.1553-2712.2011.01246.x. Epub 2012 Jan 5.

Reference Type BACKGROUND
PMID: 22221292 (View on PubMed)

Locker TE, Baston S, Mason SM, Nicholl J. Defining frequent use of an urban emergency department. Emerg Med J. 2007 Jun;24(6):398-401. doi: 10.1136/emj.2006.043844.

Reference Type BACKGROUND
PMID: 17513534 (View on PubMed)

van Tiel S, Rood PP, Bertoli-Avella AM, Erasmus V, Haagsma J, van Beeck E, Patka P, Polinder S. Systematic review of frequent users of emergency departments in non-US hospitals: state of the art. Eur J Emerg Med. 2015 Oct;22(5):306-15. doi: 10.1097/MEJ.0000000000000242.

Reference Type BACKGROUND
PMID: 25647038 (View on PubMed)

Huang JA, Tsai WC, Chen YC, Hu WH, Yang DY. Factors associated with frequent use of emergency services in a medical center. J Formos Med Assoc. 2003 Apr;102(4):222-8.

Reference Type BACKGROUND
PMID: 12833184 (View on PubMed)

LaCalle E, Rabin E. Frequent users of emergency departments: the myths, the data, and the policy implications. Ann Emerg Med. 2010 Jul;56(1):42-8. doi: 10.1016/j.annemergmed.2010.01.032. Epub 2010 Mar 26.

Reference Type BACKGROUND
PMID: 20346540 (View on PubMed)

Bergeron P, Courteau J, Vanasse A. Proximity and emergency department use: Multilevel analysis using administrative data from patients with cardiovascular risk factors. Can Fam Physician. 2015 Aug;61(8):e391-7.

Reference Type BACKGROUND
PMID: 26505061 (View on PubMed)

Byrne M, Murphy AW, Plunkett PK, McGee HM, Murray A, Bury G. Frequent attenders to an emergency department: a study of primary health care use, medical profile, and psychosocial characteristics. Ann Emerg Med. 2003 Mar;41(3):309-18. doi: 10.1067/mem.2003.68.

Reference Type BACKGROUND
PMID: 12605196 (View on PubMed)

Vu F, Daeppen JB, Hugli O, Iglesias K, Stucki S, Paroz S, Canepa Allen M, Bodenmann P. Screening of mental health and substance users in frequent users of a general Swiss emergency department. BMC Emerg Med. 2015 Oct 9;15:27. doi: 10.1186/s12873-015-0053-2.

Reference Type BACKGROUND
PMID: 26452550 (View on PubMed)

Althaus F, Paroz S, Hugli O, Ghali WA, Daeppen JB, Peytremann-Bridevaux I, Bodenmann P. Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med. 2011 Jul;58(1):41-52.e42. doi: 10.1016/j.annemergmed.2011.03.007.

Reference Type BACKGROUND
PMID: 21689565 (View on PubMed)

Grazioli VS, Moullin JC, Kasztura M, Canepa-Allen M, Hugli O, Griffin J, Vu F, Hudon C, Jackson Y, Wolff H, Burnand B, Daeppen JB, Bodenmann P. Implementing a case management intervention for frequent users of the emergency department (I-CaM): an effectiveness-implementation hybrid trial study protocol. BMC Health Serv Res. 2019 Jan 11;19(1):28. doi: 10.1186/s12913-018-3852-9.

Reference Type DERIVED
PMID: 30634955 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

407440_167341-FNS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.